創新醫美科技之價值主張、市場認知與採用機制研究—以醫美療程EMFACE菲斯波為例

Abstract

非侵入式醫學美容療程近年來已成為全球醫美市場的重要成長動能，市場競爭焦點逐漸由技術規格與療效比較，延伸至價值主張建構、市場認知形成與消費者採用機制。面對台灣年約600億新台幣的醫美市場，現有研究多聚焦於醫美療程之臨床效果與安全性評估，較少從創新管理觀點探討創新醫美科技如何被市場理解、接受與擴散，探討創新醫美科技之價值主張、市場認知與採用機制。本研究以EMFACE菲斯波為研究個案，分析其在台灣非侵入式抗老市場中的導入策略與競爭挑戰。研究方法採質性個案研究法，透過深度訪談醫美醫師、消費者及相關產業人士，並結合產業報告、學術文獻與市場資料進行分析。研究架構以創新擴散理論（Diffusion of Innovation）、消費者行為理論、品牌定位與價值主張理論為基礎，探討創新技術如何透過市場溝通與價值轉譯影響採用行為。 研究結果發現，創新醫美科技之市場成功關鍵除了來自技術創新本身，更取決於價值主張轉譯、市場認知建立與採用機制設計。相較於成熟品類透過既有需求競爭市場占有率，EMFACE所面臨之主要挑戰在於新品類導入與需求創造，其市場障礙並非技術驗證不足，而是消費者與市場對「肌肉抗老」概念缺乏既有認知基礎。此外，本研究發現醫美市場具有不同於一般消費市場之多層次採用特性，創新技術需同時獲得醫師專業採用、諮詢師價值轉譯與消費者認知接受，方能形成有效市場擴散。 基於研究結果，本研究進一步提出「創新醫美科技採用模型」，說明創新技術須經歷技術創新、價值主張轉譯、市場認知建立、專業採用與消費者採用等階段，方能形成市場擴散效果。本研究除補充醫美科技創新擴散相關研究外，亦可作為醫美品牌、市場策略制定與新品類導入之實務參考。

In recent years, non-invasive aesthetic medical treatments have become one of the major growth drivers of the global aesthetic medicine industry. Market competition has gradually shifted from technological specifications and treatment efficacy toward value proposition development, market perception formation, and adoption mechanisms. However, existing studies primarily focus on clinical outcomes and safety evaluations, while limited attention has been given to how innovative aesthetic medical technologies are understood, accepted, and diffused from an innovation management perspective. This study adopts EMFACE as a case study to examine the value proposition, market perception, and adoption mechanisms of innovative aesthetic medical technology. It further explores the market introduction strategies and competitive challenges faced by EMFACE in Taiwan’s non-invasive facial rejuvenation market. A qualitative case study approach was employed, incorporating in-depth interviews with aesthetic physicians, consumers, and industry professionals, supplemented by industry reports, academic literature, and market data. The analytical framework integrates Diffusion of Innovation Theory, Consumer Behavior Theory, Brand Positioning Theory, and Value Proposition Theory. The findings suggest that the market success of innovative aesthetic medical technologies depends not only on technological innovation itself, but also on effective value translation, market perception development, and adoption mechanism design. Unlike established treatment categories that compete within existing consumer demand, EMFACE faces the challenge of category creation and demand generation. The primary barrier is not technological validation but the lack of consumer understanding regarding the concept of muscle-based facial aging. Furthermore, the study identifies a multi-level adoption structure unique to the aesthetic medical industry, where successful diffusion requires acceptance from physicians, effective value translation by consultants, and adoption by consumers. Based on these findings, this study proposes an “Innovative Aesthetic Medical Technology Adoption Model,” illustrating how technological innovation must progress through value proposition translation, market perception development, professional adoption, and consumer adoption before achieving widespread market diffusion. The study contributes to the literature on innovation diffusion in aesthetic medicine and provides practical implications for aesthetic medical brands, marketing strategy development, and new category introduction.